ICCC
HealthcareImmuCell Corporation
$6.05
+$0.13 (+2.20%)
Jan 5, 2026
Price History (1Y)
Analysis
ImmuCell Corporation is a biotechnology company in the healthcare sector with 77 employees. The company's market capitalization stands at $54.73 million, while its revenue for the trailing twelve months (TTM) was $27.77 million. Financially, ImmuCell Corporation reported a gross margin of 42.4%, an operating margin of 0.4%, and a profit margin of 8.4% for the TTM period. The company's return on equity (ROE) was 8.3%, while its return on assets (ROA) was 3.8%. ImmuCell Corporation has $13.61 million in debt, but also holds $3.89 million in cash. ImmuCell Corporation's valuation metrics include a price-to-earnings ratio of 20.86 and a forward price-to-earnings ratio of -55.00. The company's revenue growth over the past year was -8.4%.
This analysis is AI-generated for informational purposes only and should not be considered financial advice. Data may be delayed or inaccurate. Always do your own research and consult a qualified financial advisor before making investment decisions.
About ImmuCell Corporation
ImmuCell Corporation, an animal health company, develops, manufactures, and sells products that enhance the health and productivity of dairy and beef cattle in the United States and internationally. It operates through two segments: Scours and Mastitis. The company offers First Defense, an orally delivered scours preventive product for calves with claims against E. coli, coronavirus, and rotavirus; and Tri-Shield First Defense, a passive antibody product for the treatment of E. coli, coronavirus, and rotavirus. It also provides California Mastitis Test, a quick on-farm diagnostic that is used to detect somatic cell counts in milk, as well as to determine, which quarter of the udder is mastitic; and Dual-Force First Defense, a bivalent gel tube formulation. In addition, the company developing Re-Tain Drug Product, a Nisin-based intramammary treatment of subclinical mastitis in lactating dairy cows. It sells its products through animal health distributors. ImmuCell Corporation was incorporated in 1982 and is headquartered in Portland, Maine.
Visit website →Key Statistics
- Market Cap
- $54.73M
- P/E Ratio
- 20.86
- 52-Week High
- $7.60
- 52-Week Low
- $4.28
- Avg Volume
- 25.67K
- Beta
- 0.19
Company Info
- Industry
- Biotechnology
- Exchange
- NCM
- Country
- United States
- Employees
- 77